Long-term CD4+ lymphocyte response after starting HAART in U.S. Military
Author Information
Author(s): Lifson Alan R, Krantz Elizabeth M, Eberly Lynn E, Dolan Matthew J, Marconi Vincent C, Weintrob Amy C, Crum-Cianflone Nancy F, Ganesan Anuradha, Grambsch Patricia L, Agan Brian K
Primary Institution: Infectious Disease Clinical Research Program (IDCRP)
Hypothesis
Will CD4+ levels continue to increase or plateau after 4-6 years of HAART?
Conclusion
Small but positive long-term increases in CD4+ count in virally suppressed patients were observed.
Supporting Evidence
- CD4+ count at HAART initiation was ≤ 200 cells/mm3 for 23% of participants.
- The greatest CD4+ increases occurred in the first 6 months post-HAART.
- CD4+ responses were poorer in those with longer time from HIV seroconversion to HAART start.
- Viral load suppressors showed continued increases of 12-16 cells/year.
- Clinical AIDS prior to HAART was associated with poorer CD4+ response.
Takeaway
When people with HIV start treatment early, their immune system can get better over time, even years later.
Methodology
Analyzed data from a prospective HIV military cohort study with CD4+ measurements post-HAART.
Potential Biases
Potential unmeasured confounding due to non-randomized group differences.
Limitations
The study may not represent all populations due to specific demographic factors and the healthy survivor effect.
Participant Demographics
96% male, median age 36 years.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI 122.0, 137.8
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website